Cholesterol Drug Prevents Heart Attacks — But It Doesn’t Come Cheap
A cholesterol-lowering drug called Repatha cuts the risk of heart attacks, strokes and heart-related death by 20 percent, according to a new study.
Cost and Quality
1,241 - 1,260 of 3,361 Results
-
-
$89,000 Orphan Drug Gets A New Owner — And Likely A New Price
Marathon, maker of an expensive treatment for Duchenne muscular dystrophy, sells the drug for $140 million in cash and stock to PTC Therapeutics.
-
Repeal & Replace Watch
Once Nearly Buried By Medical Bills, Farmer Braces For Insurance Drought
Barton County, Mo., is Trump country. And this rural area has big problems when it comes to health care. One farmer says he has a lot to lose under the Republican replacement plan.
-
Experimental Stem Cell Treatment Leaves Three Women Blind
Researchers, who detail the women’s experiences in the New England Journal of Medicine, say it exposes the need for better regulation of clinical trials.
-
Where You Live May Determine How You Die. Oregon Leads The Way.
A state with integrated systems for end-of-life care offers better treatment for the seriously ill, according to a new study.
-
Treating Cancer: Hope Vs. Hype
Sticker Shock Forces Thousands Of Cancer Patients To Skip Drugs, Skimp On Treatment
A growing number of patients fail to fill prescriptions because the cost of cancer drugs is too high.
By Liz Szabo -
Repeal & Replace Watch
Companies Behind Health Savings Accounts Could Bank On Big Profits Under GOP Plan
With Republicans in control of Congress and the White House, HSAs — a longtime favorite of conservatives — are likely to get a boost.
By Chad Terhune and Julie Appleby -
To Save On Drug Costs, Insurer Wants To Steer You To ‘Preferred’ Pharmacies
Blue Shield of California is hoping to steer consumers to "preferred" pharmacies where drugs are cheaper and copays lower.
-
Repeal & Replace Watch
Trump, Dems Look For Common Ground On Drug Prices
Two Democratic congressmen met with President Trump to seek his support for a bill to expand the government’s ability to negotiate drug prices, but it’s not clear it would have much impact or will gain support.
-
Three Key Senators Ask GAO To Investigate Possible Abuses Of The Orphan Drug Act
Amid an uproar over high drug prices, three GOP senators are asking the Government Accountability Office to investigate whether the Orphan Drug Act is being abused.
By Sarah Jane Tribble and Sydney Lupkin -
Are Virtual Doctor Visits Really Cost-Effective? Not So Much, Study Says
Rand Corp. finds that telehealth encourages patients to seek care for minor illnesses they wouldn’t bother to make an office visit for, raising overall health costs.
-
Cancer Rates Dropped During The Recession. That’s Not Necessarily A Good Thing.
Researchers believe Californians, many of whom lost health coverage, delayed doctor visits that could have led to earlier detection. Now, with people seeking medical care under the Affordable Care Act, some experts expect to see an increase in late-stage cancers.
-
Repeal & Replace Watch
House GOP Health Bill Jettisons Insurance Mandate, Much Of Medicaid Expansion
After intense negotiations among party factions, Republican leaders unveil legislation that committees will mark up this week.
By Mary Agnes Carey and Phil Galewitz -
‘Right-To-Try’ Laws Expose Dying Patients To Exploitation, Ethicists Warn
More than 30 states have laws on the books to allow dying patients the right to try experimental treatments. But these treatments may not be covered by insurance, and ethicists worry vulnerable people could be exploited near the end of their lives. The laws may also duplicate a process the FDA already has in place.
-
Patient Advocacy Groups Rake In Donations From Pharma
A new study shows that 83 percent of the largest patient advocacy groups take contributions from drug, medical device or biotech firms.
By Emily Kopp -
Repeal & Replace Watch
Video Highlights: Trump Promises To Lower Cost Of Health Insurance
President Trump called on Republicans and Democrats to work together to repeal and replace Obamacare.
-
Instead Of Trashing A $600 EpiPen, Some Patients Get A Refill
Epinephrine, the active ingredient in EpiPens, expires after 18 months, and the auto-injector device can’t be refilled or reused. Health professionals are looking for work-arounds they say could save the health system millions.
-
President Trump And I Take The Same Drugs — Except One
An aging writer discovers there are worse things than going bald after examining the side effects of a popular hair loss drug purportedly used by President Donald Trump.
-
Repeal & Replace Watch
Indiana’s Claims About Its Medicaid Experiment Don’t All Check Out
Indiana's conservative take on Medicaid expansion is up for renewal in the home state of Vice President Mike Pence. But there are some discrepancies between the state's application for renewal and facts about the program.
-
For Some Hospice Patients, A 911 Call Saves A Trip To The ER
Hospice groups are teaming up with specially trained paramedics to deal with common problems that worried patients or families incorrectly think need hospital care.